Breaking News

A new theory on why most U.S. bird flu cases have so far been mild

July 23, 2025
A view of Hazard, Kentucky, where coal mining boomed in the 20th century but has since largely disappeared
Natosha Via for STAT

Kentucky's campaign to improve rural cancer care is a national model. Federal cuts threaten its progress

Kentucky has improved rural cancer care access and quality, but looming Medicaid cuts threaten hospitals, screenings, and preventive services

By Ted Alcorn


HHS Secretary RFK Jr. accepts recommendations to drop thimerosal from U.S. flu vaccines

Thimerosal, long a target of anti-vaccine activists despite ample safety evidence, was recommended for removal from flu vaccines by Kennedy's expert advisors.

By Helen Branswell


New study advances theory on why most U.S. bird flu cases have so far been mild

New study using ferrets, closest animal model for human flu, found influenza A infection, H1N1 in particular, may boost immunity to avian flu.

By Helen Branswell



Alex Hogan/STAT

STAT goes on a MAHA food crawl

In STATus Report Episode 7, Alex Hogan puts MAHA-inspired foods to the test — beef tallow fries, cane sugar Coca-Cola, and ice cream without artificial dyes.

By Alex Hogan


Researchers sequence complex parts of human genome, expanding the future of precision medicine

"Landmark" study published in Nature solves 92% of missing data in the human genome, offers unprecedented map of genomic variation across ancestries.

By Veronica Paulus


STAT+ | Apple and Elevance's asthma study shows wearables can help improve health for lower-income people, too 

A digital intervention using the Apple Watch and a smartphone app helped people on Medicaid better control their asthma.

By Mario Aguilar


Dispatch Bio's executive leadership team (from left to right): Jennifer Flaisher, chief people and culture officer; Naveen Bazaj, senior vice president, corporate development; Barbra Sasu, chief scientific officer; Carl June, Perelman School of Medicine, University of Pennsylvania; Sabah Oney, CEO; Jeff Marrazzo, chairman and co-founder, former CEO, Spark Therapeutics; Lex Johnson, co-founder and chief platform officer; Chris Wiwi, senior vice president, technical operations.
Courtesy Jeremy Messler

STAT+ | Solid tumors have challenged CAR-T developers. This biotech raised $216 million to test a new approach

Dispatch Bio is developing a universal immunotherapy by trying to install a synthetic protein — called the "flare" antigen — on every cancer cell in a patient's body.

By Angus Chen and Allison DeAngelis


Opinion: Climate disasters create life-threatening disruptions for people on methadone

Communities most susceptible to natural disasters have the least access to methadone treatment and are most likely to suffer disruptions to treatment.

By Leslie W. Suen, Kate E. Roberts, and Rachel Luba


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Daily Recap? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2025, All Rights Reserved.

No comments